Shah Capital to step back from activist role at Novavax

Shah Capital will step back from its activist role at Novavax, the vaccine maker.

Shah Capital is a shareholder that has taken an activist role in the company.

The available information gives no reason for the decision or details of what that role involved.

It also does not say whether Shah Capital will sell any of its Novavax shares.

The move concerns a major shareholder's involvement in Novavax and may affect how it engages with the company.

No next steps or timing are specified.